Advancedmolecular
Epigenetic Mechanisms
Overview
Epigenetics is heritable change in gene activity without altering DNA sequence: DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs together form cellular memory. Writers add marks, readers interpret them, erasers remove them. Epigenetic programs drive development, X-inactivation, imprinting, and when disrupted, cancer and developmental disorders.
Learning objectives
- Define epigenetics and its molecular marks
- Explain writers, readers, erasers
- Describe epigenetic inheritance through mitosis
- Connect epigenetic disruption to disease
What epigenetics is
Waddington's 1942 term now means mitotically (sometimes meiotically) heritable gene-activity states without DNA sequence change. The marks: 5-methylcytosine on DNA, >100 histone post-translational modifications, ATP-dependent remodelers that slide/evict nucleosomes, and regulatory RNAs.
Epigenetics is how one genome encodes hundreds of stable cell types.
Writers, readers, erasers
Writers: DNMTs (methylate DNA), HATs (acetylate histones), HMTs (methylate histones). Readers: MBD proteins, bromodomains (acetyl-lysine), chromodomains (methyl-lysine) that recruit effectors. Erasers: TET enzymes (demethylate via oxidation), HDACs, demethylases. Drugs target these (DNMT and HDAC inhibitors in cancer).
Azacitidine (DNMT inhibitor) and vorinostat (HDAC inhibitor) are approved epigenetic cancer drugs.
Inheritance of marks
DNMT1 copies methylation onto daughter strands at replication (maintenance methylation); histone marks are partitioned with old histones and re-established by reader-writer feedback loops. This is cellular memory: daughter cells remember they are liver cells without any DNA change.
Most marks reset in the germline; true transgenerational epigenetic inheritance in mammals is rare and contested.
When epigenetics fails
Cancer: global hypomethylation plus tumor-suppressor promoter hypermethylation. Imprinting disorders: Prader-Willi/Angelman from 15q11-13 errors. Rett syndrome: MECP2 (methyl-DNA reader) mutations. Environmental inputs (diet, stress, toxins) modulate marks, the mechanistic basis of gene-environment interaction.
Marks record exposures and developmental history in chemical form on chromatin.
Key points
- Epigenetics: heritable activity states without sequence change
- Writers add, readers interpret, erasers remove marks
- DNMT1 maintains methylation through replication: cellular memory
- Disruption causes cancer, imprinting disorders, Rett syndrome
Common misconceptions
✓ Truth: By definition they do not; they modify DNA/chromatin chemistry around the same sequence.
✓ Truth: Most reset during gametogenesis/early embryogenesis; mammalian transgenerational inheritance is exceptional.
Practice questions
Q1. Maintenance of DNA methylation through replication is done by
- DNMT3a
- DNMT1
- TET1
- HDAC
DNMT1 copies methylation to daughter strands (maintenance); DNMT3s do de novo methylation.
Q2. Bromodomains read which modified residue?
- Methylated DNA
- Acetylated histone lysines
- RNA
- ATP
Bromodomains bind acetyl-lysine; chromodomains bind methyl-lysine.
Q3. Rett syndrome is caused by mutations in
- DNMT1
- MECP2, a methyl-DNA reader
- BRCA1
- CFTR
Loss of the methyl-CpG reader disrupts neuronal gene regulation.
Click a question to reveal the answer and explanation.
Frequently asked questions
What is the agouti mouse experiment?
Maternal methyl-donor diet shifted Avy offspring coat color and disease risk: diet altering epigenetic state, famously visualized.
How do HDAC inhibitors treat cancer?
By reopening chromatin at silenced tumor suppressors, restoring their expression in malignant cells.
Do identical twins stay epigenetically identical?
No: their epigenomes diverge with age and experience ('epigenetic drift'), contributing to discordant disease.